Novel role of toll-like receptors in Helicobacter pylori-induced gastric malignancy

World Journal of Gastroenterology

Volumn 20, Issue 18, 2014, Pages 5244-5251

  Uno, Kaname ^a   Kato, Katsuaki ^b   Shimosegawa, Tooru ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b MIYAGI CANCER CENTER   (Japan)

Author keywords

Damage associated molecular patterns; Gastric cancer; Helicobacter pylori; Pathogen associated molecular patterns; Toll like receptors

Indexed keywords

DNA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; LIPOPROTEIN; LIPOTEICHOIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDOGLYCAN; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; AUTACOID;

ARTICLE; CANCER GROWTH; CANCER RISK; CARCINOGENESIS; DISEASE ASSOCIATION; DNA POLYMORPHISM; HELICOBACTER INFECTION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; META ANALYSIS (TOPIC); NONHUMAN; PATHOPHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; TUMOR MICROENVIRONMENT; ANIMAL; CELL TRANSFORMATION; COMPLICATION; HELICOBACTER PYLORI; IMMUNOLOGY; MICROBIOLOGY; PATHOGENICITY; SIGNAL TRANSDUCTION; STOMACH; STOMACH TUMOR;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; SIGNAL TRANSDUCTION; STOMACH; STOMACH NEOPLASMS; TOLL-LIKE RECEPTORS; TUMOR MICROENVIRONMENT;

EID: 84900428353     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i18.5244     Document Type: Article

References (76)

1. Hofman P, Waidner B, Hofman V, Bereswill S, Brest P, Kist M. Pathogenesis of Helicobacter pylori infection. Helicobacter 2004; 9 Suppl 1: 15-22 [PMID: 15347301 DOI: 10.1111/ j.1083-4389.2004.00246.x]
2. McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med 2010; 362: 1597-1604 [PMID: 20427808 DOI: 10.1056/NEJMcp1001110]
3. Hessey SJ, Spencer J, Wyatt JI, Sobala G, Rathbone BJ, Axon AT, Dixon MF. Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut 1990; 31: 134-138 [PMID: 2311970 DOI: 10.1136/gut.31.2.134]
4. Wilson KT, Crabtree JE. Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology 2007; 133: 288-308 [PMID: 17631150 DOI: 10.1053/j.gastro.2007.05.008]
5. Sánchez-Zauco NA, Torres J, Pérez-Figueroa GE, Álvarez-Arellano L, Camorlinga-Ponce M, Gómez A, Giono-Cerezo S, Maldonado-Bernal C. Impact of cagPAI and T4SS on the inflammatory response of human neutrophils to Helicobacter pylori infection. PLoS One 2013; 8: e64623 [PMID: 23755130 DOI: 10.1371/journal.pone.0064623]
6. Correa P. New strategies for the prevention of gastric cancer: Helicobacter pylori and genetic susceptibility. J Surg Oncol 2005; 90: 134-138; discussion 138 [PMID: 15895454 DOI: 10.1002/jso.20216]
7. Konturek SJ, Starzynska T, Konturek PC, Karczewska E, Marlicz K, Lawniczak M, Jaroszewicz-Heigelman H, Bielanski W, Hartwich A, Ziemniak A, Hahn EG. Helicobacter pylori and CagA status, serum gastrin, interleukin-8 and gastric acid secretion in gastric cancer. Scand J Gastroenterol 2002; 37: 891-898 [PMID: 12229962 DOI: 10.1080/003655202760230838]
8. Nedrud JG, Blanchard SS, Czinn SJ. Helicobacter pylori inflammation and immunity. Helicobacter 2002; 7 Suppl 1: 24-29 [PMID: 12197906 DOI: 10.1046/j.1523-5378.7.s1.4.x]
9. Rassow J. Helicobacter pylori vacuolating toxin A and apoptosis. Cell Commun Signal 2011; 9: 26 [PMID: 22044628 DOI: 10.1186/1478-811X-9-26]
10. Fries PN, Griebel PJ. Mucosal dendritic cell diversity in the gastrointestinal tract. Cell Tissue Res 2011; 343: 33-41 [PMID: 20824287 DOI: 10.1007/s00441-010-1030-4]
11. Patel MK, Trombly MI, Kurt-Jones EA. Innate immune responses to Helicobacter pylori infection: an overview. Methods Mol Biol 2012; 921: 205-207 [PMID: 23015506 DOI: 10.1007/978-1-62703-005-2_23]
12. Cario E. Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2. Gut 2005; 54: 1182-1193 [PMID: 15840688 DOI: 10.1136/gut.2004.062794]
13. Hansson GK, Edfeldt K. Toll to be paid at the gateway to the vessel wall. Arterioscler Thromb Vasc Biol 2005; 25: 1085-1087 [PMID: 15923538 DOI: 10.1161/01.ATV.0000168894.43759.47]
14. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005; 17: 1-14 [PMID: 15585605 DOI: 10.1093/intimm/ dxh186]
15. Broz P, Monack DM. Newly described pattern recognition receptors team up against intracellular pathogens. Nat Rev Immunol 2013; 13: 551-565 [PMID: 23846113 DOI: 10.1038/ nri3479]
16. Mann DL. The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls. Circ Res 2011; 108: 1133-1145 [PMID: 21527743 DOI: 10.1161/CIRCRESAHA. 110.226936]
17. Backert S, Naumann M. What a disorder: proinflammatory signaling pathways induced by Helicobacter pylori. Trends Microbiol 2010; 18: 479-486 [PMID: 20863705 DOI: 10.1016/ j.tim.2010.08.003]
18. Shaykhiev R, Bals R. Interactions between epithelial cells and leukocytes in immunity and tissue homeostasis. J Leukoc Biol 2007; 82: 1-15 [PMID: 17452476 DOI: 10.1189/jlb.0207096]
19. Uno K, Kato K, Atsumi T, Suzuki T, Yoshitake J, Morita H, Ohara S, Kotake Y, Shimosegawa T, Yoshimura T. Tolllike receptor (TLR) 2 induced through TLR4 signaling initiated by Helicobacter pylori cooperatively amplifies iNOS induction in gastric epithelial cells. Am J Physiol Gastrointest Liver Physiol 2007; 293: G1004-G1012 [PMID: 17855767 DOI: 10.1152/ajpgi.00096.2007]
20. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5: 987-995 [PMID: 15454922 DOI: 10.1038/ni1112]
21. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011; 34: 637-650 [PMID: 21616434 DOI: 10.1016/ j.immuni.2011.05.006]
22. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003; 425: 516-521 [PMID: 14520412 DOI: 10.1038/nature01991]
23. Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, Dagnelie PC. Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 2006; 112: 358-404 [PMID: 16784779 DOI: 10.1016/j.pharmthera.2005.04.013]
24. Wen S, Felley CP, Bouzourene H, Reimers M, Michetti P, Pan-Hammarström Q. Inflammatory gene profiles in gastric mucosa during Helicobacter pylori infection in humans. J Immunol 2004; 172: 2595-2606 [PMID: 14764733]
25. Schmausser B, Andrulis M, Endrich S, Lee SK, Josenhans C, Müller-Hermelink HK, Eck M. Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin Exp Immunol 2004; 136: 521-526 [PMID: 15147355]
26. Maeda S, Akanuma M, Mitsuno Y, Hirata Y, Ogura K, Yoshida H, Shiratori Y, Omata M. Distinct mechanism of Helicobacter pylori-mediated NF-kappa B activation between gastric cancer cells and monocytic cells. J Biol Chem 2001; 276: 44856-44864 [PMID: 11546774 DOI: 10.1074/jbc.M105381200]
27. Kawahara T, Kuwano Y, Teshima-Kondo S, Kawai T, Nikawa T, Kishi K, Rokutan K. Toll-like receptor 4 regulates gastric pit cell responses to Helicobacter pylori infection. J Med Invest 2001; 48: 190-197 [PMID: 11694959]
28. Su B, Ceponis PJ, Lebel S, Huynh H, Sherman PM. Helicobacter pylori activates Toll-like receptor 4 expression in gastrointestinal epithelial cells. Infect Immun 2003; 71: 3496-3502 [PMID: 12761134 DOI: 10.1128/IAI.71.6.3496-3502.2003]
29. Ishihara S, Rumi MA, Kadowaki Y, Ortega-Cava CF, Yuki T, Yoshino N, Miyaoka Y, Kazumori H, Ishimura N, Amano Y, Kinoshita Y. Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritis. J Immunol 2004; 173: 1406-1416 [PMID: 15240737]
30. Kawahara T, Teshima S, Oka A, Sugiyama T, Kishi K, Rokutan K. Type I Helicobacter pylori lipopolysaccharide stimulates toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells. Infect Immun 2001; 69: 4382-4389 [PMID: 11401977 DOI: 10.1128/IAI.69.7.4382-4389.2001]
31. Chochi K, Ichikura T, Kinoshita M, Majima T, Shinomiya N, Tsujimoto H, Kawabata T, Sugasawa H, Ono S, Seki S, Mochizuki H. Helicobacter pylori augments growth of gastric cancers via the lipopolysaccharide-toll-like receptor 4 pathway whereas its lipopolysaccharide attenuates antitumor activities of human mononuclear cells. Clin Cancer Res 2008; 14: 2909-2917 [PMID: 18483357 DOI: 10.1158/1078-0432. CCR-07-4467]
32. Smith MF, Mitchell A, Li G, Ding S, Fitzmaurice AM, Ryan K, Crowe S, Goldberg JB. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J Biol Chem 2003; 278: 32552-32560 [PMID: 12807870 DOI: 10.1074/jbc.M305536200]
33. Bäckhed F, Rokbi B, Torstensson E, Zhao Y, Nilsson C, Seguin D, Normark S, Buchan AM, Richter-Dahlfors A. Gastric mucosal recognition of Helicobacter pylori is independent of Toll-like receptor 4. J Infect Dis 2003; 187: 829-836 [PMID: 12599057 DOI: 10.1086/367896]
34. Peek RM, Fiske C, Wilson KT. Role of innate immunity in Helicobacter pylori-induced gastric malignancy. Physiol Rev 2010; 90: 831-858 [PMID: 20664074 DOI: 10.1152/physrev. 00039.2009]
35. Suda Y, Ogawa T, Kashihara W, Oikawa M, Shimoyama T, Hayashi T, Tamura T, Kusumoto S. Chemical structure of lipid A from Helicobacter pylori strain 206-1 lipopolysaccharide. J Biochem 1997; 121: 1129-1133 [PMID: 9354387 DOI: 10.1093/oxfordjournals.jbchem.a021705]
36. Moran AP. Cell surface characteristics of Helicobacter pylori. FEMS Immunol Med Microbiol 1995; 10: 271-280 [PMID: 7773243 DOI: 10.1111/j.1574-695X.1995.tb00043.x]
37. Ding SZ, Torok AM, Smith MF, Goldberg JB. Toll-like receptor 2-mediated gene expression in epithelial cells during Helicobacter pylori infection. Helicobacter 2005; 10: 193-204 [PMID: 15904477 DOI: 10.1111/j.1523-5378.2005.00311.x]
38. Smith SM, Moran AP, Duggan SP, Ahmed SE, Mohamed AS, Windle HJ, O'Neill LA, Kelleher DP. Tribbles 3: a novel regulator of TLR2-mediated signaling in response to Helicobacter pylori lipopolysaccharide. J Immunol 2011; 186: 2462-2471 [PMID: 21220698 DOI: 10.4049/jimmunol.1000864]
39. Amedei A, Cappon A, Codolo G, Cabrelle A, Polenghi A, Benagiano M, Tasca E, Azzurri A, D'Elios MM, Del Prete G, de Bernard M. The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J Clin Invest 2006; 116: 1092-1101 [PMID: 16543949 DOI: 10.1172/ JCI27177]
40. Mandell L, Moran AP, Cocchiarella A, Houghton J, Taylor N, Fox JG, Wang TC, Kurt-Jones EA. Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4. Infect Immun 2004; 72: 6446-6454 [PMID: 15501775 DOI: 10.1128/IAI.72.11.6446-6454.2004]
41. Matsuguchi T, Musikacharoen T, Ogawa T, Yoshikai Y. Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages. J Immunol 2000; 165: 5767-5772 [PMID: 11067935]
42. Chang YJ, Wu MS, Lin JT, Chen CC. Helicobacter pylori-Induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through TLR2/TLR9 and promoter regulation. J Immunol 2005; 175: 8242-8252 [PMID: 16339564]
43. Yokota S, Okabayashi T, Rehli M, Fujii N, Amano K. Helicobacter pylori lipopolysaccharides upregulate toll-like receptor 4 expression and proliferation of gastric epithelial cells via the MEK1/2-ERK1/2 mitogen-activated protein kinase pathway. Infect Immun 2010; 78: 468-476 [PMID: 19858308 DOI: 10.1128/IAI.00903-09]
44. Lepper PM, Triantafilou M, Schumann C, Schneider EM, Triantafilou K. Lipopolysaccharides from Helicobacter pylori can act as antagonists for Toll-like receptor 4. Cell Microbiol 2005; 7: 519-528 [PMID: 15760452 DOI: 10.1111/ j.1462-5822.2005.00482.x]
45. Obonyo M, Sabet M, Cole SP, Ebmeyer J, Uematsu S, Akira S, Guiney DG. Deficiencies of myeloid differentiation factor 88, Toll-like receptor 2 (TLR2), or TLR4 produce specific defects in macrophage cytokine secretion induced by Helicobacter pylori. Infect Immun 2007; 75: 2408-2414 [PMID: 17353291 DOI: 10.1128/IAI.01794-06]
46. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol 2000; 165: 618-622 [PMID: 10878331]
47. Kodama K, Sumii K, Kawano M, Kido T, Nojima K, Sumii M, Haruma K, Yoshihara M, Chayama K. Gastric juice nitrite and vitamin C in patients with gastric cancer and atrophic gastritis: is low acidity solely responsible for cancer risk? Eur J Gastroenterol Hepatol 2003; 15: 987-993 [PMID: 12923371 DOI: 10.1097/00042737-200309000-00008]
48. Torok AM, Bouton AH, Goldberg JB. Helicobacter pylori induces interleukin-8 secretion by Toll-like receptor 2-and Toll-like receptor 5-dependent and-independent pathways. Infect Immun 2005; 73: 1523-1531 [PMID: 15731050 DOI: 10.1128/IAI.73.3.1523-1531.2005]
49. Schmausser B, Andrulis M, Endrich S, Müller-Hermelink HK, Eck M. Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori. Int J Med Microbiol 2005; 295: 179-185 [PMID: 16044857 DOI: 10.1016/j.ijmm.2005.02.009]
50. Lee SK, Stack A, Katzowitsch E, Aizawa SI, Suerbaum S, Josenhans C. Helicobacter pylori flagellins have very low intrinsic activity to stimulate human gastric epithelial cells via TLR5. Microbes Infect 2003; 5: 1345-1356 [PMID: 14670447 DOI: 10.1016/j.micinf.2003.09.018]
51. Andersen-Nissen E, Smith KD, Strobe KL, Barrett SL, Cookson BT, Logan SM, Aderem A. Evasion of Toll-like receptor 5 by flagellated bacteria. Proc Natl Acad Sci USA 2005; 102: 9247-9252 [PMID: 15956202 DOI: 10.1073/pnas.0502040102]
52. Gewirtz AT, Yu Y, Krishna US, Israel DA, Lyons SL, Peek RM. Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity. J Infect Dis 2004; 189: 1914-1920 [PMID: 15122529 DOI: 10.1086/386289]
53. Otani K, Tanigawa T, Watanabe T, Nadatani Y, Sogawa M, Yamagami H, Shiba M, Watanabe K, Tominaga K, Fujiwara Y, Arakawa T. Toll-like receptor 9 signaling has anti-inflammatory effects on the early phase of Helicobacter pyloriinduced gastritis. Biochem Biophys Res Commun 2012; 426: 342-349 [PMID: 22940550 DOI: 10.1016/j.bbrc.2012.08.080]
54. Rad R, Ballhorn W, Voland P, Eisenächer K, Mages J, Rad L, Ferstl R, Lang R, Wagner H, Schmid RM, Bauer S, Prinz C, Kirschning CJ, Krug A. Extracellular and intracellular pattern recognition receptors cooperate in the recognition of Helicobacter pylori. Gastroenterology 2009; 136: 2247-2257 [PMID: 19272387 DOI: 10.1053/j.gastro.2009.02.066]
55. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994; 61: 1-241 [PMID: 7715068]
56. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009; 30: 1073-1081 [PMID: 19468060 DOI: 10.1093/carcin/bgp127]
57. Pimentel-Nunes P, Gonçalves N, Boal-Carvalho I, Afonso L, Lopes P, Roncon-Albuquerque R, Henrique R, Moreira-Dias L, Leite-Moreira AF, Dinis-Ribeiro M. Helicobacter pylori induces increased expression of Toll-like receptors and decreased Toll-interacting protein in gastric mucosa that persists throughout gastric carcinogenesis. Helicobacter 2013; 18: 22-32 [PMID: 23061653 DOI: 10.1111/hel.12008]
58. Tye H, Kennedy CL, Najdovska M, McLeod L, McCormack W, Hughes N, Dev A, Sievert W, Ooi CH, Ishikawa TO, Oshima H, Bhathal PS, Parker AE, Oshima M, Tan P, Jenkins BJ. STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation. Cancer Cell 2012; 22: 466-478 [PMID: 23079657 DOI: 10.1016/j.ccr.2012.08.010]
59. Tye H, Jenkins BJ. Tying the knot between cytokine and tolllike receptor signaling in gastrointestinal tract cancers. Cancer Sci 2013; 104: 1139-1145 [PMID: 23710764 DOI: 10.1111/ cas.12205]
60. Grivennikov SI, Karin M. Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev 2010; 21: 11-19 [PMID: 20018552 DOI: 10.1016/j.cytogfr.2009.11.005]
61. Deng JY, Sun D, Liu XY, Pan Y, Liang H. STAT-3 correlates with lymph node metastasis and cell survival in gastric cancer. World J Gastroenterol 2010; 16: 5380-5387 [PMID: 21072904 DOI: 10.3748/wjg.v16.i42.5380]
62. Herrera V, Parsonnet J. Helicobacter pylori and gastric adenocarcinoma. Clin Microbiol Infect 2009; 15: 971-976 [PMID: 19874380 DOI: 10.1111/j.1469-0691.2009.03031.x]
63. Mayerle J, den Hoed CM, Schurmann C, Stolk L, Homuth G, Peters MJ, Capelle LG, Zimmermann K, Rivadeneira F, Gruska S, Völzke H, de Vries AC, Völker U, Teumer A, van Meurs JB, Steinmetz I, Nauck M, Ernst F, Weiss FU, Hofman A, Zenker M, Kroemer HK, Prokisch H, Uitterlinden AG, Lerch MM, Kuipers EJ. Identification of genetic loci associated with Helicobacter pylori serologic status. JAMA 2013; 309: 1912-1920 [PMID: 23652523 DOI: 10.1001/jama.2013.4350]
64. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25: 187-191 [PMID: 10835634 DOI: 10.1038/76048]
65. de Oliveira JG, Silva AE. Polymorphisms of the TLR2 and TLR4 genes are associated with risk of gastric cancer in a Brazilian population. World J Gastroenterol 2012; 18: 1235-1242 [PMID: 22468087 DOI: 10.3748/wjg.v18.i11.1235]
66. Schmidt HM, Ha DM, Taylor EF, Kovach Z, Goh KL, Fock KM, Barrett JH, Forman D, Mitchell H. Variation in human genetic polymorphisms, their association with Helicobacter pylori acquisition and gastric cancer in a multi-ethnic country. J Gastroenterol Hepatol 2011; 26: 1725-1732 [PMID: 21649724 DOI: 10.1111/j.1440-1746.2011.06799.x]
67. Santini D, Angeletti S, Ruzzo A, Dicuonzo G, Galluzzo S, Vincenzi B, Calvieri A, Pizzagalli F, Graziano N, Ferraro E, Lorino G, Altomare A, Magnani M, Graziano F, Tonini G. Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes. Clin Exp Immunol 2008; 154: 360-364 [PMID: 18826495 DOI: 10.1111/j.1365-2249.2008.03776.x]
68. Hold GL, Rabkin CS, Chow WH, Smith MG, Gammon MD, Risch HA, Vaughan TL, McColl KE, Lissowska J, Zatonski W, Schoenberg JB, Blot WJ, Mowat NA, Fraumeni JF, El-Omar EM. A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 2007; 132: 905-912 [PMID: 17324405 DOI: 10.1053/ j.gastro.2006.12.026]
69. Garza-Gonzalez E, Bosques-Padilla FJ, Mendoza-Ibarra SI, Flores-Gutierrez JP, Maldonado-Garza HJ, Perez-Perez GI. Assessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8-251 polymorphisms in the risk for the development of distal gastric cancer. BMC Cancer 2007; 7: 70 [PMID: 17462092 DOI: 10.1186/1471-2407-7-70]
70. Castaño-Rodríguez N, Kaakoush NO, Goh KL, Fock KM, Mitchell HM. The role of TLR2, TLR4 and CD14 genetic polymorphisms in gastric carcinogenesis: a case-control study and meta-analysis. PLoS One 2013; 8: e60327 [PMID: 23565226 DOI: 10.1371/journal.pone.0060327]
71. Kupcinskas J, Wex T, Bornschein J, Selgrad M, Leja M, Juozaityte E, Kiudelis G, Jonaitis L, Malfertheiner P. Lack of association between gene polymorphisms of Angiotensin converting enzyme, Nod-like receptor 1, Toll-like receptor 4, FAS/FASL and the presence of Helicobacter pylori-induced premalignant gastric lesions and gastric cancer in Caucasians. BMC Med Genet 2011; 12: 112 [PMID: 21864388 DOI: 10.1186/1471-2350-12-112]
72. Hishida A, Matsuo K, Goto Y, Mitsuda Y, Hiraki A, Naito M, Wakai K, Tajima K, Hamajima N. Toll-like receptor 4 +3725 G/C polymorphism, Helicobacter pylori seropositivity, and the risk of gastric atrophy and gastric cancer in Japanese. Helicobacter 2009; 14: 47-53 [PMID: 19191896 DOI: 10.1111/ j.1523-5378.2009.00659.x]
73. Tahara T, Arisawa T, Wang F, Shibata T, Nakamura M, Sakata M, Hirata I, Nakano H. Toll-like receptor 2-196 to 174del polymorphism influences the susceptibility of Japanese people to gastric cancer. Cancer Sci 2007; 98: 1790-1794 [PMID: 17711514 DOI: 10.1111/j.1349-7006.2007.00590.x]
74. Zeng HM, Pan KF, Zhang Y, Zhang L, Ma JL, Zhou T, Su HJ, Li WQ, Li JY, Gerhard M, Classen M, You WC. Genetic variants of toll-like receptor 2 and 5, helicobacter pylori infection, and risk of gastric cancer and its precursors in a chinese population. Cancer Epidemiol Biomarkers Prev 2011; 20: 2594-2602 [PMID: 21994405 DOI: 10.1158/1055-9965.EPI-11-0702]
75. Wang X, Xue L, Yang Y, Xu L, Zhang G. TLR9 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis. PLoS One 2013; 8: e65731 [PMID: 23776537 DOI: 10.1371/journal. pone.0065731]
76. Hold GL, Rabkin CS, Gammon MD, Berry SH, Smith MG, Lissowska J, Risch HA, Chow WH, Mowat NA, Vaughan TL, El-Omar EM. CD14-159C/T and TLR9-1237T/C polymorphisms are not associated with gastric cancer risk in Caucasian populations. Eur J Cancer Prev 2009; 18: 117-119 [PMID: 19337058 DOI: 10.1097/CEJ.0b013e3283101292]